Middle East & Africa Pharma ADMET Testing Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis By Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, and In Silico ADMET Testing), Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others) 

No. of Pages: 127
Report Code: BMIRE00026956
Category: Life Sciences
Middle East & Africa Pharma ADMET Testing Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East & Africa Pharma ADMET Testing Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Pharma ADMET Testing Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East & Africa Pharma ADMET Testing Market Regional Analysis

6.2 Middle East & Africa Pharma ADMET Testing Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa Pharma ADMET Testing Market Forecast Analysis

7. Middle East & Africa Pharma ADMET Testing Market Analysis – by Testing Type

7.1 In Vivo ADMET Testing
  • 7.1.1 Overview
  • 7.1.2 In Vivo ADMET Testing: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 In Vitro ADMET Testing
  • 7.2.1 Overview
  • 7.2.2 In Vitro ADMET Testing: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 In Silico ADMET Testing
  • 7.3.1 Overview
  • 7.3.2 In Silico ADMET Testing: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Middle East & Africa Pharma ADMET Testing Market Analysis – by Technology

8.1 Cell Culture
  • 8.1.1 Overview
  • 8.1.2 Cell Culture: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 High Throughput
  • 8.2.1 Overview
  • 8.2.2 High Throughput: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Molecular Imaging
  • 8.3.1 Overview
  • 8.3.2 Molecular Imaging: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 OMICS Technology
  • 8.4.1 Overview
  • 8.4.2 OMICS Technology: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Middle East & Africa Pharma ADMET Testing Market Analysis – by Application

9.1 Systemic Toxicity
  • 9.1.1 Overview
  • 9.1.2 Systemic Toxicity: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Renal Toxicity
  • 9.2.1 Overview
  • 9.2.2 Renal Toxicity: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Hepatotoxicity
  • 9.3.1 Overview
  • 9.3.2 Hepatotoxicity: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Neurotoxicity
  • 9.4.1 Overview
  • 9.4.2 Neurotoxicity: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Middle East & Africa Pharma ADMET Testing Market – Middle East and Africa Analysis

10.1 Overview

10.2 Middle East and Africa
  • 10.2.1 Middle East & Africa Pharma ADMET Testing Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.2.1.1 Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 South Africa: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 South Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Testing Type
    • 10.2.1.1.2 South Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Technology
    • 10.2.1.1.3 South Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Application
  • 10.2.1.2 Saudi Arabia: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Saudi Arabia: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Testing Type
    • 10.2.1.2.2 Saudi Arabia: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Technology
    • 10.2.1.2.3 Saudi Arabia: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Application
  • 10.2.1.3 UAE: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 UAE: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Testing Type
    • 10.2.1.3.2 UAE: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Technology
    • 10.2.1.3.3 UAE: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Application
  • 10.2.1.4 Rest of Middle East and Africa: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Testing Type
    • 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Technology
    • 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Agilent Technologies, Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bio-Rad Laboratories, Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Biovia (Dassault Systèmes)
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Charles River Laboratories
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 IQVIA Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 MERCK KGaA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Promega Corporation
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Wuxi AppTec
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Middle East & Africa Pharma ADMET Testing Market

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biovia (Dassault Systèmes)
  • Charles River Laboratories
  • IQVIA Inc.
  • MERCK KGaA
  • Promega Corporation
  • Wuxi AppTec
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)